Introduction:

BPC-157 is a potent peptide that has a wide range of effects on the body. Research has shown that it can be used to treat many different pathologies across the body. No wonder it is known as the wolverine peptide because of its aggressive and hardy nature. The brain especially can be treated by BPC-157 through the gut by the gut-brain axis. It has been shown to decrease demyelination, decrease the damage of Parkinson’s disease, and improve serotonin and dopamine levels. BPC-157 could be one of the major keys to unlocking longer life and healthy aging as it combats neurocognitive diseases.

Future Research

• Conduct human studies on BPC-157 and Multiple sclerosis.

• Conduct human studies on depression and BPC-157.

• Farther investigate the pathway of the JAX-2 pathway and how it is affected by BPC-157.

• Look into the effects of motor function and BPC-157 on humans.

References

National Center for Biotechnology Information (2020). PubChem Compound Summary for CID 108101. Retrieved August 4, 2020 from https://pubchem.ncbi.nlm.nih.gov/compound/108101

Sikiric, P., Seiwerth, S., Rucman, R., Kolenc, D., Vuletic, L. B., Drmic, D., Grgic, T., Strbe, S., Zukanovic, G., Crvenkovic, D., Madzarac, G., Rukavina, I., Sucic, M., Baric, M., Starcevic, N., Krstonijevic, Z., Bencic, M. L., Filipcic, I., Rokotov, D. S., & Vlainic, J. (2016). Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Current neuropharmacology, 14(8), 857–865. https://doi.org/10.2174/1570159x13666160502153022

O’Mahony et al., 2015 S.M. O’Mahony, G. Clarke, Y.E. Borre, T.G. Dinan, J.F. Cryan Serotonin, tryptophan metabolism and the brain-gut-microbiome axis Behav. Brain Res. (2015), 10.1016/j.bbr.2014.07.027

Peters R. (2006). Ageing and the brain. Postgraduate medical journal, 82(964), 84–88. https://doi.org/10.1136/pgmj.2005.036665

Carabotti, M., Scirocco, A., Maselli, M. A., & Severi, C. (2015). The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Annals of gastroenterology, 28(2), 203–209.

Sikiric, P., Jelovac, N., Jelovac-Gjeldum, A., Dodig, G., Staresinic, M., Anic, T., Zoricic, I., Rak, D., Perovic, D., Aralica, G., Buljat, G., Prkacin, I., Lovric-Bencic, M., Separovic, J., Seiwerth, S., Rucman, R., Petek, M., Turkovic, B., Ziger, T., Boban-Blagaic, A., … Babic, S. (2002). Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances. Acta pharmacologica Sinica, 23(5), 412–422.

 Carabotti, M., Scirocco, A., Maselli, M. A., & Severi, C. (2015). The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Annals of gastroenterology, 28(2), 203–209.

Peters R. (2006). Ageing and the brain. Postgraduate medical journal, 82(964), 84–88. https://doi.org/10.1136/pgmj.2005.036665

Biology Support Site. (n.d.). Retrieved from https://www.philpoteducation.com/mod/book/view.php?id=817#/

Wallace J. L. (2006). Nitric oxide, aspirin-triggered lipoxins and NO-aspirin in gastric protection. Inflammation & allergy drug targets, 5(2), 133–137. https://doi.org/10.2174/187152806776383116

Chibueze, I. (n.d.). International Journal of Clinical and Medical Cases: Novel Therapeutic Options for Prevention and Treatment of Peptic Ulcer Disease. Retrieved from https://www.boffinaccess.com/open-access-journals/clinical-and-medical-cases/novel-therapeutic-options-ijcmc-1-109.php

 Sian J, Youdim MBH, Riederer P, et al. MPTP-Induced Parkinsonian Syndrome. In: Siegel GJ, Agranoff BW, Albers RW, et al., editors. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition. Philadelphia: Lippincott-Raven; 1999. Available from: https://www.ncbi.nlm.nih.gov/books/NBK27974/

Carabotti, M., Scirocco, A., Maselli, M. A., & Severi, C. (2015). The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Annals of gastroenterology, 28(2), 203–209.

Miki, Y. (2019), Magnetic resonance imaging diagnosis of demyelinating diseases: An update. Clin Exp Neuroimmunol, 10: 32-48. doi:10.1111/cen3.12501